(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics Top 10 Companies >  Leading Diagnostics Companies R&D Expenditures and Major Programs

Leading Diagnostics Companies R&D Expenditures and Major Programs



 

For each company, the report provides:
  • R&D budget, research facilities, and staff.
  • New technologies, systems, and applications in development, including their specifications and anticipated introduction dates.
The companies analyzed in the report: Abbott, Bayer Diabetes, Beckman Coulter, Becton Dickinson, bioMerieux, Bio-Rad, J&J, Roche, Siemens, and Sysmex.

Contains 57 pages



To order sections of this report, contact Client Services


     
   
Local PDF: $2450.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X